BE725169A - - Google Patents

Info

Publication number
BE725169A
BE725169A BE725169DA BE725169A BE 725169 A BE725169 A BE 725169A BE 725169D A BE725169D A BE 725169DA BE 725169 A BE725169 A BE 725169A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR132112A external-priority patent/FR6978M/fr
Priority claimed from FR159646A external-priority patent/FR7978M/fr
Application filed filed Critical
Publication of BE725169A publication Critical patent/BE725169A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/625—Salicylic acid; Derivatives thereof having heterocyclic substituents, e.g. 4-salicycloylmorpholine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • C07D231/26—1-Phenyl-3-methyl-5- pyrazolones, unsubstituted or substituted on the phenyl ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE725169D 1967-12-13 1968-12-09 BE725169A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR132112A FR6978M (fr) 1967-12-13 1967-12-13
FR149541 1968-04-25
FR159646A FR7978M (fr) 1968-07-18 1968-07-18

Publications (1)

Publication Number Publication Date
BE725169A true BE725169A (fr) 1969-05-16

Family

ID=27244735

Family Applications (1)

Application Number Title Priority Date Filing Date
BE725169D BE725169A (fr) 1967-12-13 1968-12-09

Country Status (5)

Country Link
BE (1) BE725169A (fr)
CH (1) CH510617A (fr)
DE (1) DE1814607A1 (fr)
GB (1) GB1244185A (fr)
NL (1) NL6817989A (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2755224A1 (de) * 1976-12-15 1978-07-13 Procter & Gamble Schmerzen und entzuendungen linderndes mittel zur oertlichen anwendung
GB8304990D0 (en) * 1983-02-23 1983-03-30 Procter & Gamble Detergent ingredients
GB2349880A (en) * 1999-05-10 2000-11-15 Secr Defence (Thio)morpholinium salts having SHG activity
US6436916B1 (en) * 2000-10-12 2002-08-20 Alvin Guttag Ibuprofen-aspirin and hydroxymethylacylfulvene analogs

Also Published As

Publication number Publication date
NL6817989A (fr) 1969-06-17
GB1244185A (en) 1971-08-25
DE1814607A1 (de) 1969-07-24
CH510617A (fr) 1971-07-31

Similar Documents

Publication Publication Date Title
AU425114B2 (fr)
AU416737B2 (fr)
AU2277767A (fr)
AU342066A (fr)
AU610966A (fr)
AU2528767A (fr)
AU2256867A (fr)
AU3189468A (fr)
AU3151267A (fr)
AU2454867A (fr)
AU2977667A (fr)
BE692780A (fr)
BE514578A (fr)
AU3054676A (fr)
AU2406369A (fr)
BE426053A (fr)
AU1763766A (fr)
AU34866A (fr)
AU408412B2 (fr)
AU1677166A (fr)
AU1614766A (fr)
BE483855A (fr)
BE710617A (fr)
BE710977A (fr)
BE711423A (fr)